Topics

Selecta Biosciences, Inc. Company Profile

04:12 EST 20th February 2020 | BioPortfolio

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Selecta's proprietary Synthetic Vaccine Particle (SVP™) platform creates a new paradigm in vaccine development, enabling completely new therapeutic applications while offering the potential of improved efficacy and safety profiles. Selecta’s fully synthetic engineering of novel vaccines offers a number of compelling benefits, including flexible modular vaccine design and accelerated development timelines using robust manufacturing processes. Selecta’s SVP™ platform technology is flexible to enable diverse vaccines and the company has created targeted antigen-specific Synthetic Vaccine Particles (tSVP™) and targeted antigen-specific tolerogenic Synthetic Vaccine Particles (t2SVP™).


News Articles [611 Associated News Articles listed on BioPortfolio]

Selecta Biosciences and AskBio Announce Strategic Partnership

Selecta Biosciences (NASDAQ:SELB) and Asklepios BioPharmaceutical have announced a strategic partnership to develop targeted therapeutics for adeno-associated virus (AAV) gene therapies. As quoted in ...

Sanofi’s Alison Schecter Tapped as Selecta Bio Chief Medical Officer

Selecta Biosciences (NASDAQ: SELB) has appointed Alison Schecter to serve as chief medical officer. Schecter joins Watertown, MA-based Selecta from Sanofi (NYSE: SNY) where she was global project head...

Selecta Biosciences to Present at the Janney Healthcare Conference

WATERTOWN, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic thera...

Selecta Biosciences Announces $70 Million Private Placement

WATERTOWN, Mass., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therap...

Selecta Biosciences to Present at the Stifel 2019 Healthcare Conference

WATERTOWN, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therap...

Selecta Biosciences Appoints Carrie S. Cox as Chairman of its Board of Directors

– Former Chairman, CEO, and senior executive at numerous biotechnology and pharmaceutical companies brings strong clinical and commercial experience to support advancement of the Company’s ...

Selecta Biosciences to Present at the 9th Annual SVB Leerink Global Healthcare Conference

WATERTOWN, Mass., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therap...

Selecta Biosciences Appoints Alison Schecter, M.D., as Chief Medical Officer

WATERTOWN, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies ba...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Eptifibatide [amneal biosciences]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION . EPTIFIBATIDE injection,...

Natelle one [meda pharmaceuticals]

natelleONE

Isoproterenol hydrochloride [amneal biosciences llc]

Isoproterenol Hydrochloride Injection, USP Rx only Sterile Injection

Spherusol [nielsen biosciences, inc.]

These highlights do not include all the information needed to use Spherusol safely and effectively. See full prescribing information for Spherusol . Coccidioides immitis Spherule-Derived Skin Test Ant...

Natelle one [azur pharma, inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [56 Associated PubMed Articles listed on BioPortfolio]

Heineken, Tsuchiya and Aris on the Mathematical Status of the Pseudo-steady State Hypothesis: a Classic from Volume 1 of Mathematical Biosciences.

Volume 1, Issue 1 of Mathematical Biosciences was the venue for a now-classic paper on the application of singular perturbation theory in enzyme kinetics, "On the mathematical status of the pseudo-ste...

Introduction.

A genomic extension to the sequence of HLA-A*02:13, identified using Third-Generation Sequencing.

Pacific Biosciences' SMRT sequencing method was used to extend the sequence of HLA-A*02:13. This article is protected by copyright. All rights reserved.

How the diversity of the faces arises.

The evolution of the face is crucial for each species to adapt to different diets, environments, and in some species, to promote social interaction. The diversity in the shapes of the face results fro...

BacPipe: A Rapid, User-Friendly Whole-Genome Sequencing Pipeline for Clinical Diagnostic Bacteriology.

Despite rapid advances in whole genome sequencing (WGS) technologies, their integration into routine microbiological diagnostics has been hampered by the lack of standardized downstream bioinformatics...

Clinical Trials [16 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer

The drug for this submission is Hope Biosciences' allogeneic, first blood relative, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSCs) for the treatment of a single patien...

Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Parkinson's Disease

The drug for this submission is Hope Biosciences' autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSC's) for the treatment of a single patient with Parkinson's Di...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Companies [410 Associated Companies listed on BioPortfolio]

Selecta Biosciences, Inc.

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen...

Selecta Biosciences, Inc. and Genethon

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Selecta Biosciences, Inc." on BioPortfolio

We have published hundreds of Selecta Biosciences, Inc. news stories on BioPortfolio along with dozens of Selecta Biosciences, Inc. Clinical Trials and PubMed Articles about Selecta Biosciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Selecta Biosciences, Inc. Companies in our database. You can also find out about relevant Selecta Biosciences, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...


Corporate Database Quicklinks



Searches Linking to this Company Record